Envision Healthcare Corporation has announced its acquisition by global investment firm KKR.
As a result of the completion of the merger, Envision has become a wholly owned subsidiary of funds affiliated with KKR, and Envision stockholders will receive an amount in cash equal to USD46.00 per share of Envision common stock.
As a result of the completion of the merger, shares of Envision’s common stock ceased trading on the NYSE prior to the opening of the NYSE today.
